Works matching IS 13520504 AND DT 2009 AND VI 16 AND IP 8

Results: 8

The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 537, doi. 10.1111/j.1365-2893.2009.01089.x

By:

Long, Y.;
Chen, E.;
Liu, C.;
Huang, F.;
Zhou, T.;
He, F.;
Liu, L.;
Liu, F.;
Tang, H.

Publication type:

Article

Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 547, doi. 10.1111/j.1365-2893.2009.01092.x

By:

Pham, T. N. Q.;
Mercer, S. E.;
Michalak, T. I.

Publication type:

Article

Treatment of hepatitis C infection for current or former substance abusers in a community setting.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 557, doi. 10.1111/j.1365-2893.2009.01097.x

By:

John-Baptiste, A.;
Varenbut, M.;
Lingley, M.;
Nedd-Roderique, T.;
Teplin, D.;
Tomlinson, G.;
Daiter, J.;
Krahn, M.

Publication type:

Article

Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 568, doi. 10.1111/j.1365-2893.2009.01105.x

By:

van den Berg, C. H. S. B.;
van de Laar, T. J. W.;
Kok, A.;
Zuure, F. R.;
Coutinho, R. A.;
Prins, M.

Publication type:

Article

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 586, doi. 10.1111/j.1365-2893.2009.01106.x

By:

Hiramatsu, N.;
Oze, T.;
Yakushijin, T.;
Inoue, Y.;
Igura, T.;
Mochizuki, K.;
Imanaka, K.;
Kaneko, A.;
Oshita, M.;
Hagiwara, H.;
Mita, E.;
Nagase, T.;
Ito, T.;
Inui, Y.;
Hijioka, T.;
Katayama, K.;
Tamura, S.;
Yoshihara, H.;
Imai, Y.;
Kato, M.

Publication type:

Article

Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 595, doi. 10.1111/j.1365-2893.2009.01109.x

By:

Cannon, N. A.;
Donlin, M. J.;
Mayes, L. M.;
Lyra, A. C.;
Di Bisceglie, A. M.;
Tavis, J. E.

Publication type:

Article

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 578, doi. 10.1111/j.1365-2893.2009.01116.x

By:

Oze, T.;
Hiramatsu, N.;
Yakushijin, T.;
Kurokawa, M.;
Igura, T.;
Mochizuki, K.;
Imanaka, K.;
Yamada, A.;
Oshita, M.;
Hagiwara, H.;
Mita, E.;
Ito, T.;
Inui, Y.;
Hijioka, T.;
Tamura, S.;
Yoshihara, H.;
Hayashi, E.;
Inoue, A.;
Imai, Y.;
Kato, M.

Publication type:

Article

Implication of normal liver enzymes in liver disease.

Published in:

Journal of Viral Hepatitis, 2009, v. 16, n. 8, p. 529, doi. 10.1111/j.1365-2893.2009.01150.x

By:

Calvaruso, Vincenza;
Craxì, Antonio

Publication type:

Article